SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

09 May 2022 Evaluate

Pursuant to Regulation 29, 33 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fredun Pharmaceuticals has informed that the meeting of the Board of Directors of the company is scheduled to be held on Monday 16th May, 2022 to consider and approve the following: Audited Financial Results for the last quarter and financial year ended March 31, 2022 along with the Statement of Assets and Liabilities and Cash Flow statement as on that date, Audited Financial Statements for the Financial Year ended March 31, 2022 and Recommend dividend for the Financial Year ended March 31, 2022 subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. Further, in continuation of its  intimation dated March 31, 2022 and pursuant to Company's ‘Code of Conduct’ formed under the Securities and Exchange Board of India (Prohibition of Insider Trading Regulations, 2015 and amendments thereunder, the trading window for dealing in the securities of the Company has been closed from April 01, 2022 and it shall remain closed until forty-eight hours after the date of declaration of results for the quarter and year ended March 31, 2022. The same has been circulated to the Directors, Key Managerial Personnel, Employees of the Company and their immediate relatives.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

2134.50 90.60 (4.43%)
22-Apr-2026 12:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1659.60
Dr. Reddys Lab 1220.85
Cipla 1235.35
Zydus Lifesciences 930.00
Lupin 2309.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×